As of 11:49am ET
| +0.37 / +0.37%|
The 7 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 132.20, with a high estimate of 155.00 and a low estimate of 128.00. The median estimate represents a +32.46% increase from the last price of 99.80.
The current consensus among 7 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.